Roivant Sciences Ltd (NASDAQ: ROIV) is -9.81% lower on its value in year-to-date trading and has touched a low of $8.73 and a high of $13.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ROIV stock was last observed hovering at around $10.76 in the last trading session, with the day’s loss setting it -0.09%.
Currently trading at $10.67, the stock is -2.30% and 1.10% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.28 million and changing -0.84% at the moment leaves the stock -5.20% off its SMA200. ROIV registered -4.13% loss for a year compared to 6-month loss of -10.11%.
The stock witnessed a 4.71% gain in the last 1 month and extending the period to 3 months gives it a 2.20%, and is -4.48% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.74% over the week and 2.99% over the month.
Roivant Sciences Ltd (ROIV) has around 908 employees, a market worth around $7.61B and $97.56M in sales. Profit margin for the company is -119.54%. Distance from 52-week low is 22.22% and -18.27% from its 52-week high. The company has generated returns on investments over the last 12 months (-2.21%).
The EPS is expected to shrink by -109.96% this year
The shares outstanding are 719.63M, and float is at 439.45M with Short Float at 12.00%.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 71.36 million shares valued at $754.29 million. The investor’s holdings represent 9.6983 of the ROIV Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.16 million shares valued at $730.98 million to account for 9.3985 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 9.0674 and valued at over $705.23 million, while FMR LLC holds 6.3265 of the shares totaling 46.55 million with a market value of $492.05 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Ramaswamy Vivek, the company’s 10% Owner. SEC filings show that Ramaswamy Vivek sold 625,000 shares of the company’s common stock on May 07 ’25 at a price of $11.18 per share for a total of $6.99 million. Following the sale, the insider now owns 39.17 million shares.
Roivant Sciences Ltd disclosed in a document filed with the SEC on May 06 ’25 that Ramaswamy Vivek (10% Owner) sold a total of 273,959 shares of the company’s common stock. The trade occurred on May 06 ’25 and was made at $11.47 per share for $3.14 million. Following the transaction, the insider now directly holds 39.8 million shares of the ROIV stock.
Still, SEC filings show that on May 07 ’25, Ramaswamy Vivek (10% Owner) Proposed Sale 625,000 shares at an average price of $11.18 for $6.99 million. The insider now directly holds shares of Roivant Sciences Ltd (ROIV).